Diagnosis and Treatment of Testosterone Deficiency: Updated Recommendations From the Lisbon 2018 International Consultation for Sexual Medicine
The International Consultation for Sexual Medicine met in Lisbon in 2018 to review updated recommendations regarding testosterone deficiency (TD) and its treatment. To provide updated clinical recommendations regarding TD and its treatment. A Medline search was performed for testosterone (T) article...
Gespeichert in:
| Veröffentlicht in: | Sexual medicine reviews 2019-10, Vol.7 (4), p.636-649 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 649 |
|---|---|
| container_issue | 4 |
| container_start_page | 636 |
| container_title | Sexual medicine reviews |
| container_volume | 7 |
| creator | Morgentaler, Abraham Traish, Abdulmaged Hackett, Geoffrey Jones, T. Hugh Ramasamy, Ranjith |
| description | The International Consultation for Sexual Medicine met in Lisbon in 2018 to review updated recommendations regarding testosterone deficiency (TD) and its treatment.
To provide updated clinical recommendations regarding TD and its treatment.
A Medline search was performed for testosterone (T) articles published since the 2015 International Consultation for Sexual Medicine report. Recommendations were presented at the Lisbon meeting, and feedback was incorporated into final recommendations.
Selected topics for these updates included terminology, clinical diagnosis, sexual function, prostate, cardiovascular, metabolic conditions, anemia, bone health, and therapeutic options.
The terms “testosterone deficiency” (TD) and “testosterone therapy” (TTh) were endorsed over numerous competing terms. The wide interindividual variability of sex hormone binding globulin concentrations influences the interpretation of total T concentrations. Symptoms of T deficiency more closely follow free T than total T concentrations. Symptomatic men with total T |
| doi_str_mv | 10.1016/j.sxmr.2019.06.003 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2266337270</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S2050052119300678</els_id><sourcerecordid>2266337270</sourcerecordid><originalsourceid>FETCH-LOGICAL-c422t-a8c9b3d1b55069931a73287641b0cfff4c138d449702851b6894a2633a554ba93</originalsourceid><addsrcrecordid>eNp9kc9u1DAQxi0EolXpC3BAPnLZ4D9xEiMuaEuh0iIk2J4tx5mAV4m92E7VPgWvzOxuQZzwxR7rN59mvo-Ql5xVnPHmza7K93OqBOO6Yk3FmHxCzgVTbMWU4E__eZ-Ry5x3DI_WUtb6OTmTXCquuTonv668_R5i9pnaMNBtAltmCIXGkW4hl5gLpBiAXsHonYfgHt7S2_1gCwz0K7g4I42VjyHT6xRnWn4A3fjcx0BxuI7eBFQIR8JOdI3cMpVjSceY6De4X_D_MwwoH-AFeTbaKcPl431Bbq8_bNefVpsvH2_W7zcrVwtRVrZzupcD75ViDa7FbStF1zY175kbx7F2XHZDXeuWiU7xvul0bUUjpVWq7q2WF-T1SXef4s8FFzWzzw6myQaISzZCNEi3omWIihPqUsw5wWj2yc82PRjOzCELszOHLMwhC8Mag1lg06tH_aWfYfjb8sd5BN6dAMAt7zwkk4_2og8JXDFD9P_T_w1qCptu</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2266337270</pqid></control><display><type>article</type><title>Diagnosis and Treatment of Testosterone Deficiency: Updated Recommendations From the Lisbon 2018 International Consultation for Sexual Medicine</title><source>MEDLINE</source><source>Oxford University Press Journals All Titles (1996-Current)</source><creator>Morgentaler, Abraham ; Traish, Abdulmaged ; Hackett, Geoffrey ; Jones, T. Hugh ; Ramasamy, Ranjith</creator><creatorcontrib>Morgentaler, Abraham ; Traish, Abdulmaged ; Hackett, Geoffrey ; Jones, T. Hugh ; Ramasamy, Ranjith</creatorcontrib><description>The International Consultation for Sexual Medicine met in Lisbon in 2018 to review updated recommendations regarding testosterone deficiency (TD) and its treatment.
To provide updated clinical recommendations regarding TD and its treatment.
A Medline search was performed for testosterone (T) articles published since the 2015 International Consultation for Sexual Medicine report. Recommendations were presented at the Lisbon meeting, and feedback was incorporated into final recommendations.
Selected topics for these updates included terminology, clinical diagnosis, sexual function, prostate, cardiovascular, metabolic conditions, anemia, bone health, and therapeutic options.
The terms “testosterone deficiency” (TD) and “testosterone therapy” (TTh) were endorsed over numerous competing terms. The wide interindividual variability of sex hormone binding globulin concentrations influences the interpretation of total T concentrations. Symptoms of T deficiency more closely follow free T than total T concentrations. Symptomatic men with total T <350 ng/dL or free T <65–100 pg/mL may reasonably undergo a trial of T therapy. An empirical 6-month trial of TTh may be considered in men with strongly suggestive symptoms and values above these thresholds. Morning blood testing is indicated in men <40 years of age. Men >40 years may undergo initial afternoon testing, as long as confirmatory morning blood tests are later obtained. High-level evidence demonstrates TTh in men with TD improves sexual desire and erectile function. The weight of evidence indicates that TTh is not associated with increased risk of prostate cancer, cardiovascular events, or worsening lower urinary tract symptoms. Bone density and anemia are improved with TTh. Obesity and type 2 diabetes are associated with TD, and TTh provides consistent improvement in metabolic parameters. Multiple safe and effective therapeutic options are available to treat men with TD.
Treatment of TD offers multiple benefits for sexual symptoms as well as for general health, without compelling evidence for increased risk of prostate cancer or cardiovascular events.
Morgentaler A, Traish A, Hackett G, et al. Diagnosis and Treatment of Testosterone Deficiency: Updated Recommendations From the Lisbon 2018 International Consultation for Sexual Medicine. Sex Med Rev 2019;7:636–649.</description><identifier>ISSN: 2050-0521</identifier><identifier>EISSN: 2050-0521</identifier><identifier>DOI: 10.1016/j.sxmr.2019.06.003</identifier><identifier>PMID: 31351915</identifier><language>eng</language><publisher>Netherlands: Elsevier Inc</publisher><subject>Anemia - etiology ; Bone Diseases - etiology ; Cardiovascular Diseases - etiology ; Clinical Trials as Topic ; Humans ; Hypogonadism ; Hypogonadism - diagnosis ; Hypogonadism - drug therapy ; Libido ; Libido - drug effects ; Male ; Prostatic Hyperplasia - chemically induced ; Prostatic Neoplasms - chemically induced ; Recommendations ; Sexual Dysfunction, Physiological - drug therapy ; Sexual Dysfunction, Physiological - etiology ; Terminology as Topic ; Testosterone ; Testosterone - deficiency ; Testosterone - therapeutic use ; Testosterone Therapy</subject><ispartof>Sexual medicine reviews, 2019-10, Vol.7 (4), p.636-649</ispartof><rights>2019</rights><rights>Copyright © 2019. Published by Elsevier Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c422t-a8c9b3d1b55069931a73287641b0cfff4c138d449702851b6894a2633a554ba93</citedby><cites>FETCH-LOGICAL-c422t-a8c9b3d1b55069931a73287641b0cfff4c138d449702851b6894a2633a554ba93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31351915$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Morgentaler, Abraham</creatorcontrib><creatorcontrib>Traish, Abdulmaged</creatorcontrib><creatorcontrib>Hackett, Geoffrey</creatorcontrib><creatorcontrib>Jones, T. Hugh</creatorcontrib><creatorcontrib>Ramasamy, Ranjith</creatorcontrib><title>Diagnosis and Treatment of Testosterone Deficiency: Updated Recommendations From the Lisbon 2018 International Consultation for Sexual Medicine</title><title>Sexual medicine reviews</title><addtitle>Sex Med Rev</addtitle><description>The International Consultation for Sexual Medicine met in Lisbon in 2018 to review updated recommendations regarding testosterone deficiency (TD) and its treatment.
To provide updated clinical recommendations regarding TD and its treatment.
A Medline search was performed for testosterone (T) articles published since the 2015 International Consultation for Sexual Medicine report. Recommendations were presented at the Lisbon meeting, and feedback was incorporated into final recommendations.
Selected topics for these updates included terminology, clinical diagnosis, sexual function, prostate, cardiovascular, metabolic conditions, anemia, bone health, and therapeutic options.
The terms “testosterone deficiency” (TD) and “testosterone therapy” (TTh) were endorsed over numerous competing terms. The wide interindividual variability of sex hormone binding globulin concentrations influences the interpretation of total T concentrations. Symptoms of T deficiency more closely follow free T than total T concentrations. Symptomatic men with total T <350 ng/dL or free T <65–100 pg/mL may reasonably undergo a trial of T therapy. An empirical 6-month trial of TTh may be considered in men with strongly suggestive symptoms and values above these thresholds. Morning blood testing is indicated in men <40 years of age. Men >40 years may undergo initial afternoon testing, as long as confirmatory morning blood tests are later obtained. High-level evidence demonstrates TTh in men with TD improves sexual desire and erectile function. The weight of evidence indicates that TTh is not associated with increased risk of prostate cancer, cardiovascular events, or worsening lower urinary tract symptoms. Bone density and anemia are improved with TTh. Obesity and type 2 diabetes are associated with TD, and TTh provides consistent improvement in metabolic parameters. Multiple safe and effective therapeutic options are available to treat men with TD.
Treatment of TD offers multiple benefits for sexual symptoms as well as for general health, without compelling evidence for increased risk of prostate cancer or cardiovascular events.
Morgentaler A, Traish A, Hackett G, et al. Diagnosis and Treatment of Testosterone Deficiency: Updated Recommendations From the Lisbon 2018 International Consultation for Sexual Medicine. Sex Med Rev 2019;7:636–649.</description><subject>Anemia - etiology</subject><subject>Bone Diseases - etiology</subject><subject>Cardiovascular Diseases - etiology</subject><subject>Clinical Trials as Topic</subject><subject>Humans</subject><subject>Hypogonadism</subject><subject>Hypogonadism - diagnosis</subject><subject>Hypogonadism - drug therapy</subject><subject>Libido</subject><subject>Libido - drug effects</subject><subject>Male</subject><subject>Prostatic Hyperplasia - chemically induced</subject><subject>Prostatic Neoplasms - chemically induced</subject><subject>Recommendations</subject><subject>Sexual Dysfunction, Physiological - drug therapy</subject><subject>Sexual Dysfunction, Physiological - etiology</subject><subject>Terminology as Topic</subject><subject>Testosterone</subject><subject>Testosterone - deficiency</subject><subject>Testosterone - therapeutic use</subject><subject>Testosterone Therapy</subject><issn>2050-0521</issn><issn>2050-0521</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kc9u1DAQxi0EolXpC3BAPnLZ4D9xEiMuaEuh0iIk2J4tx5mAV4m92E7VPgWvzOxuQZzwxR7rN59mvo-Ql5xVnPHmza7K93OqBOO6Yk3FmHxCzgVTbMWU4E__eZ-Ry5x3DI_WUtb6OTmTXCquuTonv668_R5i9pnaMNBtAltmCIXGkW4hl5gLpBiAXsHonYfgHt7S2_1gCwz0K7g4I42VjyHT6xRnWn4A3fjcx0BxuI7eBFQIR8JOdI3cMpVjSceY6De4X_D_MwwoH-AFeTbaKcPl431Bbq8_bNefVpsvH2_W7zcrVwtRVrZzupcD75ViDa7FbStF1zY175kbx7F2XHZDXeuWiU7xvul0bUUjpVWq7q2WF-T1SXef4s8FFzWzzw6myQaISzZCNEi3omWIihPqUsw5wWj2yc82PRjOzCELszOHLMwhC8Mag1lg06tH_aWfYfjb8sd5BN6dAMAt7zwkk4_2og8JXDFD9P_T_w1qCptu</recordid><startdate>201910</startdate><enddate>201910</enddate><creator>Morgentaler, Abraham</creator><creator>Traish, Abdulmaged</creator><creator>Hackett, Geoffrey</creator><creator>Jones, T. Hugh</creator><creator>Ramasamy, Ranjith</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201910</creationdate><title>Diagnosis and Treatment of Testosterone Deficiency: Updated Recommendations From the Lisbon 2018 International Consultation for Sexual Medicine</title><author>Morgentaler, Abraham ; Traish, Abdulmaged ; Hackett, Geoffrey ; Jones, T. Hugh ; Ramasamy, Ranjith</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c422t-a8c9b3d1b55069931a73287641b0cfff4c138d449702851b6894a2633a554ba93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Anemia - etiology</topic><topic>Bone Diseases - etiology</topic><topic>Cardiovascular Diseases - etiology</topic><topic>Clinical Trials as Topic</topic><topic>Humans</topic><topic>Hypogonadism</topic><topic>Hypogonadism - diagnosis</topic><topic>Hypogonadism - drug therapy</topic><topic>Libido</topic><topic>Libido - drug effects</topic><topic>Male</topic><topic>Prostatic Hyperplasia - chemically induced</topic><topic>Prostatic Neoplasms - chemically induced</topic><topic>Recommendations</topic><topic>Sexual Dysfunction, Physiological - drug therapy</topic><topic>Sexual Dysfunction, Physiological - etiology</topic><topic>Terminology as Topic</topic><topic>Testosterone</topic><topic>Testosterone - deficiency</topic><topic>Testosterone - therapeutic use</topic><topic>Testosterone Therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Morgentaler, Abraham</creatorcontrib><creatorcontrib>Traish, Abdulmaged</creatorcontrib><creatorcontrib>Hackett, Geoffrey</creatorcontrib><creatorcontrib>Jones, T. Hugh</creatorcontrib><creatorcontrib>Ramasamy, Ranjith</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Sexual medicine reviews</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Morgentaler, Abraham</au><au>Traish, Abdulmaged</au><au>Hackett, Geoffrey</au><au>Jones, T. Hugh</au><au>Ramasamy, Ranjith</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Diagnosis and Treatment of Testosterone Deficiency: Updated Recommendations From the Lisbon 2018 International Consultation for Sexual Medicine</atitle><jtitle>Sexual medicine reviews</jtitle><addtitle>Sex Med Rev</addtitle><date>2019-10</date><risdate>2019</risdate><volume>7</volume><issue>4</issue><spage>636</spage><epage>649</epage><pages>636-649</pages><issn>2050-0521</issn><eissn>2050-0521</eissn><abstract>The International Consultation for Sexual Medicine met in Lisbon in 2018 to review updated recommendations regarding testosterone deficiency (TD) and its treatment.
To provide updated clinical recommendations regarding TD and its treatment.
A Medline search was performed for testosterone (T) articles published since the 2015 International Consultation for Sexual Medicine report. Recommendations were presented at the Lisbon meeting, and feedback was incorporated into final recommendations.
Selected topics for these updates included terminology, clinical diagnosis, sexual function, prostate, cardiovascular, metabolic conditions, anemia, bone health, and therapeutic options.
The terms “testosterone deficiency” (TD) and “testosterone therapy” (TTh) were endorsed over numerous competing terms. The wide interindividual variability of sex hormone binding globulin concentrations influences the interpretation of total T concentrations. Symptoms of T deficiency more closely follow free T than total T concentrations. Symptomatic men with total T <350 ng/dL or free T <65–100 pg/mL may reasonably undergo a trial of T therapy. An empirical 6-month trial of TTh may be considered in men with strongly suggestive symptoms and values above these thresholds. Morning blood testing is indicated in men <40 years of age. Men >40 years may undergo initial afternoon testing, as long as confirmatory morning blood tests are later obtained. High-level evidence demonstrates TTh in men with TD improves sexual desire and erectile function. The weight of evidence indicates that TTh is not associated with increased risk of prostate cancer, cardiovascular events, or worsening lower urinary tract symptoms. Bone density and anemia are improved with TTh. Obesity and type 2 diabetes are associated with TD, and TTh provides consistent improvement in metabolic parameters. Multiple safe and effective therapeutic options are available to treat men with TD.
Treatment of TD offers multiple benefits for sexual symptoms as well as for general health, without compelling evidence for increased risk of prostate cancer or cardiovascular events.
Morgentaler A, Traish A, Hackett G, et al. Diagnosis and Treatment of Testosterone Deficiency: Updated Recommendations From the Lisbon 2018 International Consultation for Sexual Medicine. Sex Med Rev 2019;7:636–649.</abstract><cop>Netherlands</cop><pub>Elsevier Inc</pub><pmid>31351915</pmid><doi>10.1016/j.sxmr.2019.06.003</doi><tpages>14</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2050-0521 |
| ispartof | Sexual medicine reviews, 2019-10, Vol.7 (4), p.636-649 |
| issn | 2050-0521 2050-0521 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2266337270 |
| source | MEDLINE; Oxford University Press Journals All Titles (1996-Current) |
| subjects | Anemia - etiology Bone Diseases - etiology Cardiovascular Diseases - etiology Clinical Trials as Topic Humans Hypogonadism Hypogonadism - diagnosis Hypogonadism - drug therapy Libido Libido - drug effects Male Prostatic Hyperplasia - chemically induced Prostatic Neoplasms - chemically induced Recommendations Sexual Dysfunction, Physiological - drug therapy Sexual Dysfunction, Physiological - etiology Terminology as Topic Testosterone Testosterone - deficiency Testosterone - therapeutic use Testosterone Therapy |
| title | Diagnosis and Treatment of Testosterone Deficiency: Updated Recommendations From the Lisbon 2018 International Consultation for Sexual Medicine |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T02%3A16%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Diagnosis%20and%20Treatment%20of%20Testosterone%20Deficiency:%20Updated%20Recommendations%20From%20the%20Lisbon%202018%20International%20Consultation%20for%20Sexual%20Medicine&rft.jtitle=Sexual%20medicine%20reviews&rft.au=Morgentaler,%20Abraham&rft.date=2019-10&rft.volume=7&rft.issue=4&rft.spage=636&rft.epage=649&rft.pages=636-649&rft.issn=2050-0521&rft.eissn=2050-0521&rft_id=info:doi/10.1016/j.sxmr.2019.06.003&rft_dat=%3Cproquest_cross%3E2266337270%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2266337270&rft_id=info:pmid/31351915&rft_els_id=S2050052119300678&rfr_iscdi=true |